Wooten
Edward Wooten and Sarkis Oganyan, individually and on behalf of all others similarly situated v. BioLife Plasma Services L.P. and Takeda Pharmaceuticals U.S.A., Inc.
Opinion
trial_court Opinion
1 2 3 4 5 6 UNITED STATES DISTRICT COURT 7 EASTERN DISTRICT OF CALIFORNIA 8 9 EDWARD WOOTEN and SARKIS No. 1:25-cv-00099-KES-SKO OGANYAN, individually and on behalf of 10 all others similarly situated, 11 Plaintiffs, ORDER GRANTING DEFENDANTS’
MOTION TO DISMISS
12 v. Doc. 19 13 BIOLIFE PLASMA SERVICES L.P. and
TAKEDA PHARMACEUTICALS U.S.A.,
14 INC., 15 Defendants. 16
17 18 Plaintiffs Evan Wooten and Sarkis Oganyan proceed on their first amended class action 19 complaint (“FAC”), on behalf of themselves and others, against defendants BioLife Plasma 20 Services L.P. (“BioLife”) and Takeda Pharmaceuticals U.S.A., Inc. (“Takeda”). Doc. 17 21 (“FAC”). Plaintiffs allege that, when they created accounts on BioLife’s website, third-party 22 trackers installed by defendants, and operated by third-parties Snap and Salesforce, captured their 23 email addresses and IP addresses without their consent, in violation of the California Invasion of 24 Privacy Act (“CIPA”). Defendants move to dismiss the FAC pursuant to Federal Rules of Civil 25 Procedure 12(b)(1), 12(b)(2), and…